Raphael Pharmaceutical Inc. financial data

Symbol
RAPH on OTC
Location
Suite 105 5348 Vegas Dr., Las Vegas, NV
State of incorporation
NV
Fiscal year end
December 31
Former names
Easy Energy Inc (to 5/14/2021)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 23.8 % -75.1%
Return On Equity -8.99K % -329%
Return On Assets -1.09K % -84.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.6M shares +5.17%
Common Stock, Shares, Outstanding 18.7M shares +1.07%
Entity Public Float 17.2M USD +71.6%
Common Stock, Value, Issued 187K USD +1.08%
Weighted Average Number of Shares Outstanding, Basic 18.7M shares +11.7%
Weighted Average Number of Shares Outstanding, Diluted 18.7M shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 776K USD +36.4%
General and Administrative Expense 733K USD -3.93%
Operating Income (Loss) -1.51M USD -13.3%
Nonoperating Income (Expense) -10K USD +16.7%
Net Income (Loss) Attributable to Parent -1.52M USD -13%
Earnings Per Share, Basic 0.08 USD/shares 0%
Earnings Per Share, Diluted 0.08 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19K USD -91.7%
Other Assets, Current 6K USD -14.3%
Assets, Current 25K USD -89.5%
Property, Plant and Equipment, Net 2K USD 0%
Assets 27K USD -88.7%
Accounts Payable, Current 125K USD +81.2%
Accrued Liabilities, Current 375K USD +1400%
Liabilities, Current 769K USD +483%
Retained Earnings (Accumulated Deficit) -8.89M USD -20.6%
Stockholders' Equity Attributable to Parent -742K USD -793%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9K USD -109%
Liabilities and Equity 27K USD -88.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -172K USD +56.9%
Net Cash Provided by (Used in) Financing Activities 230K USD +54.4%
Net Cash Provided by (Used in) Investing Activities -1K USD
Common Stock, Shares Authorized 21M shares 0%
Common Stock, Shares, Issued 18.7M shares +1.07%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 57K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19K USD -91.7%
Deferred Tax Assets, Valuation Allowance 1.54M USD +21.1%
Deferred Tax Assets, Gross 1.54M USD +21.1%
Depreciation 1K USD
Payments to Acquire Property, Plant, and Equipment 1K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.97M USD +21.3%
Additional Paid in Capital 7.18M USD +52.5%